showed a trendp = 0.0511
Treatment with LFPRLR SMO also showed a trend towards reduction of Tregs in the liver, which is a major site of metastatic spread ( p = 0.0511).
Treatment with LFPRLR SMO also showed a trend towards reduction of Tregs in the liver, which is a major site of metastatic spread ( p = 0.0511).